Evidence map›Paper›PMID 34098038›Full record

ArticleContemporary clinical trials2021

Engaging smokers in research: Utility of Facebook in facilitating recruitment to a smoking cessation study.

Sarah K Cook, Rebecca N Jerome, Julia Dunagan, Nan Kennedy, Terri Edwards, Jennifer A Minnix, Leann Witmer, Jennifer Ferguson, Paul Cinciripini, Consuelo Wilkins and 1 more

Abstract read
In one paragraph

Article in Contemporary clinical trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah K CookVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA. Electronic address: sarah.k.cook@vumc.org.
Rebecca N JeromeVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA.
Julia DunaganVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA.
Nan KennedyVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA.
Terri EdwardsVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA.
Jennifer A MinnixThe University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Dan L. Duncan Building, 3rd floor, 1155 Pressler St., Houston, TX 77030, USA.
Leann WitmerThe University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Dan L. Duncan Building, 3rd floor, 1155 Pressler St., Houston, TX 77030, USA.
Jennifer FergusonThe University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Dan L. Duncan Building, 3rd floor, 1155 Pressler St., Houston, TX 77030, USA.
Paul CinciripiniThe University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Dan L. Duncan Building, 3rd floor, 1155 Pressler St., Houston, TX 77030, USA.
Consuelo WilkinsVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA; Department of Medicine, Vanderbilt University Medical Center, 1161 21st Ave S, Nashville, TN 37232, USA; Office of Health Equity, Vanderbilt University Medical Center, 2525 West End Suite 600, Nashville, TN 37203, USA; Department of Internal Medicine, Meharry Medical College, 1005 Dr. D.B. Todd, Jr. Boulevard Nashville, TN 37208, USA.
Paul HarrisVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH) - HEAL SupplementU24TR001579 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, PAUL A., WILKINS, CONSUELO HOPKINS · 2016 to 2022
$34.1M
Optimizing Effectiveness of Smoking Cessation Intervention During LDCT screening for Lung CancerR01CA207078 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CINCIRIPINI, PAUL MICHAEL · 2016 to 2021
$3.3M
NCATS NIH HHS U24 TR001579NCATS NIH HHS UL1 TR002243NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA207078
6 · The paper itself

Abstract

introductionSocial media, including Facebook outreach, is increasingly being used as a participant recruitment tool, and may be particularly useful in tobacco and smoking cessation studies. The Recruitment Innovation Center at Vanderbilt University Medical Center partnered with Project LUNA, a smoking cessation study, to conduct a pilot social media campaign aimed at increasing study recruitment.

methodsTwo posts encouraging study participation were developed and promoted on Facebook to users with an interest in smoking-related topics, with a link to a study-specific webpage. Facebook and website analytics were collected, including impressions, clicks, click-through rates, website traffic, and clicks to the study screening form. Study screening and enrollment data were also collected.

resultsThe Facebook campaign ran in June 2019 in the greater Houston area. In total, the Facebook posts logged 1,179,844 impressions, 6490 clicks, and an overall click-through rate of 0.55%. There were no differences in response to the two different promotional posts. Approximately 3812 unique individuals visited an intermediary study page, with 473 expressing interest in the study. Forty-three potential participants contacted the study team, resulting in study enrollment and randomization of 23 participants, with an estimated cost per enrolled participant of $441.

conclusionsThe social media campaign was successful at increasing outreach and interest in the LUNA study. However, the price-per-participant enrolled was higher than in comparable tobacco cessation studies. These results and lessons learned may be beneficial to others considering social media as a recruitment method for their clinical research trial.

Indexed as

Smoking CessationSocial MediaHumansSmokersSmokingTobacco SmokingClinical trial recruitmentSmoking cessationSocial media

Identifiers

PMID34098038
PMCPMC8429250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.